FDA issues new policy for evaluating impact of viral mutations on COVID-19 tests
By EsqSocial Corporation 25/02/21
The U.S. Food and Drug Administration (FDA) has issued new guidance for COVID-19 test developers to evaluate the impact of emerging and future viral mutations on COVID-19 tests. The SARS-CoV-2 virus has mutated over time, creating multiple variants of the virus with different genetic sequences....
By: Hogan Lovells